BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

859 related articles for article (PubMed ID: 10976920)

  • 1. A selective peroxisome proliferator-activated receptor-gamma (PPARgamma) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes.
    Mukherjee R; Hoener PA; Jow L; Bilakovics J; Klausing K; Mais DE; Faulkner A; Croston GE; Paterniti JR
    Mol Endocrinol; 2000 Sep; 14(9):1425-33. PubMed ID: 10976920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity.
    Rieusset J; Touri F; Michalik L; Escher P; Desvergne B; Niesor E; Wahli W
    Mol Endocrinol; 2002 Nov; 16(11):2628-44. PubMed ID: 12403851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rexinoid LG100754 is a novel RXR:PPARgamma agonist and decreases glucose levels in vivo.
    Cesario RM; Klausing K; Razzaghi H; Crombie D; Rungta D; Heyman RA; Lala DS
    Mol Endocrinol; 2001 Aug; 15(8):1360-9. PubMed ID: 11463859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel potent antagonist of peroxisome proliferator-activated receptor gamma blocks adipocyte differentiation but does not revert the phenotype of terminally differentiated adipocytes.
    Camp HS; Chaudhry A; Leff T
    Endocrinology; 2001 Jul; 142(7):3207-13. PubMed ID: 11416043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A synthetic triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), is a ligand for the peroxisome proliferator-activated receptor gamma.
    Wang Y; Porter WW; Suh N; Honda T; Gribble GW; Leesnitzer LM; Plunket KD; Mangelsdorf DJ; Blanchard SG; Willson TM; Sporn MB
    Mol Endocrinol; 2000 Oct; 14(10):1550-6. PubMed ID: 11043571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YM268 increases the glucose uptake, cell differentiation, and mRNA expression of glucose transporter in 3T3-L1 adipocytes.
    Shimaya A; Kurosaki E; Shioduka K; Nakano R; Shibasaki M; Shikama H
    Horm Metab Res; 1998 Sep; 30(9):543-8. PubMed ID: 9808320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of glucose uptake in 3T3-L1 adipocytes by PPAR gamma agonists is maintained in cells expressing a PPAR gamma dominant-negative mutant: evidence for selectivity in the downstream responses to PPAR gamma activation.
    Nugent C; Prins JB; Whitehead JP; Savage D; Wentworth JM; Chatterjee VK; O'Rahilly S
    Mol Endocrinol; 2001 Oct; 15(10):1729-38. PubMed ID: 11579205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pioglitazone ameliorates tumor necrosis factor-alpha-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator--activated receptor-gamma.
    Iwata M; Haruta T; Usui I; Takata Y; Takano A; Uno T; Kawahara J; Ueno E; Sasaoka T; Ishibashi O; Kobayashi M
    Diabetes; 2001 May; 50(5):1083-92. PubMed ID: 11334412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A synthetic antagonist for the peroxisome proliferator-activated receptor gamma inhibits adipocyte differentiation.
    Wright HM; Clish CB; Mikami T; Hauser S; Yanagi K; Hiramatsu R; Serhan CN; Spiegelman BM
    J Biol Chem; 2000 Jan; 275(3):1873-7. PubMed ID: 10636887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of peroxisome proliferator-activated receptor-gamma in maintenance of the characteristics of mature 3T3-L1 adipocytes.
    Tamori Y; Masugi J; Nishino N; Kasuga M
    Diabetes; 2002 Jul; 51(7):2045-55. PubMed ID: 12086932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of adipogenesis by a COOH-terminally truncated mutant of PPARgamma2 in 3T3-L1 cells.
    Masugi J; Tamori Y; Kasuga M
    Biochem Biophys Res Commun; 1999 Oct; 264(1):93-9. PubMed ID: 10527847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The farnesoid X receptor promotes adipocyte differentiation and regulates adipose cell function in vivo.
    Rizzo G; Disante M; Mencarelli A; Renga B; Gioiello A; Pellicciari R; Fiorucci S
    Mol Pharmacol; 2006 Oct; 70(4):1164-73. PubMed ID: 16778009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential gene regulation by PPARgamma agonist and constitutively active PPARgamma2.
    Li Y; Lazar MA
    Mol Endocrinol; 2002 May; 16(5):1040-8. PubMed ID: 11981038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific activation of the nuclear receptors PPARgamma and RORA by the antidiabetic thiazolidinedione BRL 49653 and the antiarthritic thiazolidinedione derivative CGP 52608.
    Wiesenberg I; Chiesi M; Missbach M; Spanka C; Pignat W; Carlberg C
    Mol Pharmacol; 1998 Jun; 53(6):1131-8. PubMed ID: 9614218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta -hydroxysteroid dehydrogenase type 1 expression and activity.
    Berger J; Tanen M; Elbrecht A; Hermanowski-Vosatka A; Moller DE; Wright SD; Thieringer R
    J Biol Chem; 2001 Apr; 276(16):12629-35. PubMed ID: 11278270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artepillin C, as a PPARĪ³ ligand, enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells.
    Choi SS; Cha BY; Iida K; Lee YS; Yonezawa T; Teruya T; Nagai K; Woo JT
    Biochem Pharmacol; 2011 Apr; 81(7):925-33. PubMed ID: 21219874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnolol enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells.
    Choi SS; Cha BY; Lee YS; Yonezawa T; Teruya T; Nagai K; Woo JT
    Life Sci; 2009 Jun; 84(25-26):908-14. PubMed ID: 19376135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of adipocyte differentiation by insulin-like growth factor-binding protein-3.
    Chan SS; Schedlich LJ; Twigg SM; Baxter RC
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E654-63. PubMed ID: 19141684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists.
    Mukherjee R; Davies PJ; Crombie DL; Bischoff ED; Cesario RM; Jow L; Hamann LG; Boehm MF; Mondon CE; Nadzan AM; Paterniti JR; Heyman RA
    Nature; 1997 Mar; 386(6623):407-10. PubMed ID: 9121558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stage-specific effects of a thiazolidinedione on proliferation, differentiation and PPARgamma mRNA expression in 3T3-L1 adipocytes.
    Takamura T; Nohara E; Nagai Y; Kobayashi K
    Eur J Pharmacol; 2001 Jun; 422(1-3):23-9. PubMed ID: 11430909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.